BMS 540215 - Brivanib

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1850

CAS [649735-46-6]

MF C19H19FN4O3
MW 370.38

Purity: 98%
Optical purity: Optically pure
Soluble in DMSO

BMS 540215

Description

Potent and ATP-competitive inhibitor of VEGF; it inhibits VEGFR2, -1 and -3 with IC50 of 25, 380 and 10 nM respectively; also showed good selectivity for FGFR-1, -2, and -3 with IC50 of 148, 125 and 68 nM. BMS 540215 is the active component of its prodrug, Brivalib alaninate (BMS 582664, Axon 1864), which hydrolyzes to BMS 540215 in vivo quickly

RS Bhide et al. Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor. J. Med. Chem. 2006, 49(7), 2143-2146.

ZW Cai et al. Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular (...). J. Med. Chem. 2008, 51(6), 1976-1980.

H Huynh et al. Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models (...). Clin. Cancer Res. 2008, 14, 6146.

Angiogenesis Cell Signaling & Oncology VEGFR RTK class IV; EC 2.7.10.1

Inhibitor of VEGFR (subtype 2 and 3 selective)

Chemical name

(R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol

Parent CAS No.

[649735-46-6]

Order

Size	Unit Price	Stock
5 mg	€110.00	In Stock
25 mg	€380.00	In Stock

Need more? Bulk Inquiry

Related Products

Axon ID	Name	Description	From price
1128	Erlotinib hydrochloride	EGFR tyrosine kinase inhibitor		€70.00
1393	Gefitinib	EGFR tyrosine kinase inhibitor		€70.00
1395	Lapatinib ditosylate	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€80.00
1398	Sunitinib malate	Multi-targeted receptor tyrosine kinase inhibitor		€80.00
1411	Vandetanib	VEGFR and EGFR tyrosine kinase inhibitor		€50.00
1414	AG 013736	PDGFR,c-KIT and VEGFR tyrosine kinase inhibitor		€50.00
1420	Pazopanib hydrochloride	PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor		€60.00
1433	CI 1033	EGFR tyrosine kinase inhibitor		€60.00
1461	Cediranib	VEGFR tyrosine kinase inhibitor		€70.00
1506	WZ 4002	EGFR kinase inhibitor (T790M specific)		€70.00
1526	Neratinib	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€80.00
1544	BIBW 2992	EGFR and ErbB-2/HER2 tyrosine kinase inhibitor		€50.00
1547	OSI 930	c-Kit and VEGFR2 tyrosine kinase inhibitor		€90.00
1632	OSI 420	EGFR tyrosine kinase inhibitor		€90.00
1637	Vatalanib	VEGFR tyrosine kinase inhibitor		€75.00
1638	ABT 869	PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor		€85.00
1653	AEE 788	EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor		€80.00
1662	CP 547632	VEGFR2 tyrosine kinase inhibitor		€80.00
1665	Pelitinib	EGFR tyrosine kinase inhibitor		€90.00
1678	Regorafenib	Multi-kinase RTK inhibitor		€70.00
1717	Tivozanib	VEGFR1, 2, and 3 tyrosine kinase inhibitor		€80.00
1760	EGFR Inhibitor [879127-07-8]	Highly selective EGFR tyrosine kinase inhibitor		€120.00
1768	AMG 706	Multiple receptor tyrosine kinase inhibitor		€105.00
1819	Cabozantinib S-malate	Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2		€60.00
1864	Brivanib alaninate	Prodrug of BMS 540215; Inhibitor of VEGF		€90.00
1891	SU 6668	Inhibitor of RTK targeting PDGFR, VEGF and FGFR		€100.00
1942	E 3810 dihydrochloride	Dual VEGFR/FGFR tyrosine kinase inhibitor		€90.00
1959	Golvatinib	Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2		€90.00
1963	LY 573636	Anti-tumor agent; causes growth arrest and apoptosis		€80.00
1978	ZM 323881 hydrochloride	Inhibitor of VEGFR2		€105.00
1986	AST 1306 tosylate	ErbB2 and EGFR inhibitor		€90.00
1667	SU 5402	Fibroblast growth factor receptor (FGFR) inhibitor		€60.00
2648	Nintedanib	RTK inhibitor with antiangiogenic and antineoplastic activities		€70.00
2680	EAI045	Allosteric EGFR inhibitor (L858R/T790M-specific)		€105.00
2767	SU11652	Multi-targeted receptor tyrosine kinase inhibitor		€140.00
2849	Apatinib	Inhibitor of VEGFR2		€120.00
2865	NVP-ACC789	Inhibitor of VEGFR2		€90.00
2837	BMS 605541	Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor		€90.00
3338	Taxifolin	Inhibitor of VEGFR2		€50.00
3624	Toceranib phosphate	Multi-targeted receptor tyrosine kinase inhibitor		€60.00
3946	Altiratinib	Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases		Inquire
3998	MGCD516	Orally bioavailable receptor tyrosine kinase (RTK) inhibitor	Recently added	Inquire

Customer Support

Customer Services

About Axon Medchem

Contact Us

BMS 540215 - Brivanib

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

BMS 540215 - Brivanib

Description

Chemical name

Parent CAS No.

Related Products

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us